Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial

Clinical trial NCT00795717 · COMPLETED

Trial details

NCT number: NCT00795717
Sponsor: Tufts University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Cardiovascular Disease HIV Infection

Start date: 2008-07-01
Primary completion: 2010-10-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.